trending Market Intelligence /marketintelligence/en/news-insights/trending/qyHudq_-8gELDyu4J0SD1w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Gansu Longshenrongfa Q3 profit falls YOY

An interview with Antony Jenkins, Founder & Executive Chairman, 10x Future Technologies

An interview with Nicolas Veron, Economist, Senior Fellow at Bruegel

An interview with Dan Frumkin, CEO, Metro Bank

Investment Banking: The Outlook, Market Share and Competitive Advantage


Gansu Longshenrongfa Q3 profit falls YOY

Gansu Longshenrongfa Pharmaceutical Industry Co. Ltd. said its normalized net income for the third quarter came to 4 fen per share, a decline of 30.3% from 5 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 9.4 million yuan, a decline of 22.7% from 12.1 million yuan in the year-earlier period.

The normalized profit margin dropped to 14.3% from 20.6% in the year-earlier period.

Total revenue increased 11.4% year over year to 65.5 million yuan from 58.8 million yuan, and total operating expenses grew 32.9% from the prior-year period to 52.9 million yuan from 39.8 million yuan.

Reported net income declined 19.7% from the prior-year period to 12.9 million yuan, or 5 fen per share, from 16.1 million yuan, or 7 fen per share.

As of Oct. 25, US$1 was equivalent to 6.78 yuan.